V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007850 | 240004843 | 1.63 | 47.95 | Palliative (P) | null | 2014-10-14 | R Chlorambucil | 02 | N | 240034838 | CHLORAMBUCIL + RITUXIMAB |
| 240007851 | 240004844 | 1.47 | 54.5 | Palliative (P) | null | 2014-07-16 | Chlorambucil | N | N | 240034841 | CHLORAMBUCIL |
| 240007852 | 240004845 | 1.85 | 98.6 | Neo-adjuvant (N) | 2017-05-30 | 2017-05-31 | INTERLACE TRIAL | N | N | 240034842 | INTERLACE TRIAL |
| 240007853 | 240004846 | null | 56 | Curative (C) | 2015-10-23 | 2015-11-24 | Cytarabine Low Dose | N | N | 240034844 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240007854 | 240004847 | 1.61 | 96.8 | Palliative (P) | null | 2014-01-05 | mEOC TRIAL | N | N | 240034846 | GEMCARBO |
| 240007855 | 240010689 | 1.8 | 67 | Curative (C) | 2016-07-11 | 2016-07-11 | LENALIDOMIDE | Y | N | 240034847 | AML19 TRIAL |
| 240007856 | 240004848 | 1.81 | 108 | Palliative (P) | 2013-08-03 | 2013-08-05 | Cyclophosphamide High Dose | N | N | 240034850 | BORTEZOMIB + THALIDOMIDE |
| 240007857 | 240004849 | 0 | 73.5 | Palliative (P) | 2018-01-28 | 2018-01-29 | METHOTREXATE | N | N | 240034852 | ETOPOSIDE |
| 240007858 | 240004850 | 1.6 | 66.7 | Curative (C) | 2017-09-25 | 2017-09-29 | CISPLATIN + ETOPOSIDE | 2 | N | 240034859 | CYTARABINE HD + METHOTREXATE HD |
| 240007859 | 240004850 | 1.74 | 63.8 | null | 2014-03-29 | 2014-03-30 | CISPLATIN + ETOPOSIDE | 2 | N | 240034859 | CISPLATIN + TOPOTECAN |
| 240007860 | 240004851 | 1.63 | 50.4 | null | 2015-10-02 | 2015-10-15 | FLAG | 02 | N | 240034862 | PMITCEBO-R |
| 240007861 | 240004852 | 1.81 | null | Disease modification (D) | 2015-02-27 | 2015-03-17 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | null | 240034865 | FCR |
| 240007862 | 240004853 | 1.73 | 57.6 | Palliative (P) | 2017-11-28 | 2017-11-28 | Cisplatin +Fluorouracil (3 wk) | Y | N | 240034870 | CARBOPLATIN + PEMETREXED |
| 240007863 | 240004854 | 1.71 | 79.6 | null | 2016-02-26 | 2016-02-26 | Triple Intrathecal | N | N | 240034882 | R-EPOCH |
| 240007864 | 240004854 | 1.67 | 60 | Unknown (U) | 2016-06-09 | 2016-06-09 | GEMCARBO | N | N | 240034882 | METHOTREXATE INTRATHECAL |
| 240007865 | 240004855 | 1.8 | 63.6 | Curative (C) | 2017-10-12 | 2017-10-20 | CHLVPP | 02 | N | 240034889 | AML16 TRIAL |
| 240007866 | 240004856 | 1.7 | null | Disease modification (D) | 2016-12-14 | 2016-12-14 | FCR | 02 | null | 240034894 | MITOMYCIN INTRAVESICULAR |
| 240007867 | 240004856 | 1.65 | 62 | Curative (C) | 2016-02-17 | 2016-02-17 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 240034894 | CISPLATIN + FLUOROURACIL + RT |
| 240007873 | 240004858 | null | 62.05 | Palliative (P) | 2017-10-07 | 2017-10-22 | CARBOPLATIN + RT | N | N | 240034909 | AML18 TRIAL |
| 240007874 | 240004859 | 1.67 | 90.3 | Palliative (P) | 2018-03-30 | 2018-04-12 | AML 18 TRIAL | N | N | 240034910 | GALLIUM TRIAL |
| 240007875 | 240004859 | 1.68 | 70 | Disease modification (D) | 2016-11-28 | 2016-11-23 | Cladribine + Rituximab | N | N | 240034910 | GDP |
| 240007876 | 240004860 | 0 | 55.8 | Palliative (P) | 2017-12-11 | 2017-12-19 | CVP | 02 | N | 240034914 | FEC |
| 240007877 | 240004860 | 1.57 | null | Curative (C) | 2015-10-09 | 2015-10-09 | DA-EPOCH-R | N | N | 240034914 | ERLOTINIB |
| 240007878 | 240004861 | 1.71 | 49.2 | Curative (C) | 2016-08-05 | 2016-10-20 | R-EPOCH | N | null | 240034921 | FLUOROURACIL + MITOMYCIN |
| 240007879 | 240004861 | 1.6 | 62 | Curative (C) | 2015-02-28 | 2015-02-28 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 240034921 | CISPLATIN + ETOPOSIDE |
| 240007880 | 240004862 | 0 | 72.55 | Curative (C) | 2015-07-18 | 2015-07-18 | CVP | 02 | N | 240034928 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240007881 | 240004863 | 1.64 | 73 | Palliative (P) | 2017-11-12 | 2017-11-19 | FLUOROURACIL + MITOMYCIN | 02 | null | 240034932 | TEMOZOLOMIDE |
| 240007882 | 240004863 | 1.62 | 65.2 | Not known (9) | 2014-09-07 | 2014-10-12 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINBLASTINE | N | N | 240034932 | ESHAP R |
| 240007883 | 240004864 | 1.77 | 71.8 | Disease modification (D) | 2015-11-04 | 2015-11-04 | BENDAMUSTINE + OFATUMUMAB | N | N | 240034935 | LI-1 TRIAL |
| 240007884 | 240004864 | 1.73 | 77 | Neo-adjuvant (N) | 2017-05-19 | 2017-06-03 | FCR IV - Cycle 1 | N | N | 240034935 | CYCLOPHOSPHAMIDE |
| 240007885 | 240004865 | 1.53 | 84 | Disease modification (D) | 2018-01-09 | 2018-01-19 | FLAG + Idarubicin | N | N | 240034939 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240007886 | 240004866 | 1.65 | 36.55 | Disease modification (D) | 2017-04-04 | 2017-04-05 | ENRICH Trial | N | N | 240034946 | CVP |
| 240007887 | 240004867 | 1.62 | 74 | Radical (R) | 2014-03-09 | 2014-04-26 | CVP | null | N | 240034948 | PEMBROLIZUMAB |
| 240007888 | 240004867 | null | 79.8 | Palliative (P) | 2016-05-28 | 2016-05-30 | CISPLATIN + FLUOROURACIL + RT | 02 | null | 240034948 | TOPOTECAN |
| 240007889 | 240013562 | null | null | Curative (C) | null | 2014-03-02 | CISPLATIN + FLUOROURACIL + RT | N | null | 240034955 | CISPLATIN + FLUOROURACIL + RT |
| 240007890 | 240004868 | 1.6 | 75 | Curative (C) | 2016-04-30 | 2016-06-08 | R CODOX M | 02 | N | 240034956 | CAPECITABINE |
| 240007891 | 240004868 | 1.73 | 74 | Adjuvant (A) | null | 2015-02-18 | PCV | N | Y | 240034956 | OXALIPLATIN |
| 240007892 | 240004868 | null | 58.4 | Palliative (P) | 2019-03-16 | 2019-03-16 | Cyclophosphamide + Dex + Rituximab | null | N | 240034956 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240007893 | 240004868 | 1.67 | 106 | Palliative (P) | 2018-04-13 | 2018-04-20 | GEMCARBO | N | N | 240034956 | CHOEP |
| 240007894 | 240004868 | null | 100 | Palliative (P) | 2016-12-03 | 2016-12-07 | R CODOX M | 2 | null | 240034956 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240007895 | 240004869 | 1.78 | 73 | Palliative (P) | 2017-09-30 | 2017-09-30 | CYCLOPHOSPHAMIDE | Y | N | 240034975 | CHOEP |
| 240007896 | 240004870 | 1.62 | null | Neo-adjuvant (N) | 2015-08-26 | 2015-08-26 | NHL 2003 Gp B COP | N | N | 240034983 | PMITCEBO-R |
| 240007897 | 240004871 | null | 95.1 | Palliative (P) | null | 2017-12-26 | IDARUBICIN | N | N | 240034998 | METHOTREXATE INTRATHECAL |
| 240007898 | 240010701 | 1.76 | null | Palliative (P) | 2015-11-13 | 2015-11-13 | CYTARABINE | 02 | null | 240035003 | GEMCARBO |
| 240007899 | 240004872 | 1.67 | 71.7 | Adjuvant (A) | 2015-11-09 | 2015-11-14 | Bortezomib | N | N | 240035005 | BLEOMYCIN + CISPLATIN + MTOMYCIN |
| 240007900 | 240004873 | 1.7 | 78.9 | Curative (C) | 2015-04-25 | 2015-04-25 | Triple / Double Intrathecal Therapy | 02 | N | 240035006 | CYTARABINE HD + METHOTREXATE HD |
| 240007901 | 240004874 | null | 90.9 | null | 2016-11-18 | 2016-11-22 | BORTEZOMIB + THALIDOMIDE | N | null | 240035007 | DHAP |
| 240007902 | 240004874 | 1.65 | 63 | Curative (C) | null | 2017-06-11 | Cisplatin + Etoposide + RT | null | null | 240035007 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE + RITUXIMAB |
| 240007903 | 240004875 | null | 73.3 | Curative (C) | 2013-05-21 | 2013-06-02 | DA-EPOCH-R | 02 | Y | 240035013 | NILOTINIB |
| 240007904 | 240004876 | 1.67 | 61.5 | Palliative (P) | 2016-11-14 | 2016-12-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 240035014 | VENETOCLAX |